XTL Biopharmaceuticals Ltd.

( )
XTLB After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
ARGXargenx SE -2.04%318.080.0%$122.95m
ICLRICON plc 0.69%217.582.8%$118.60m
VRXValeant Pharmaceuticals International, Inc. -1.41%9.7914.1%$57.61m
BGXXBright Green Corp. 18.04%13.280.0%$44.21m
EVOKEvoke Pharma, Inc. 961.67%2.724.2%$36.03m
RVMDRevolution Medicines, Inc. 5.72%16.630.0%$11.19m
AMRNAmarin Corp. Plc -0.70%1.411.5%$9.68m
USNAUSANA Health Sciences, Inc. -1.02%68.634.2%$4.86m
ANIKAnika Therapeutics, Inc. 0.91%21.179.8%$2.24m
ATOSAtossa Therapeutics, Inc. -4.81%0.910.2%$1.53m
NATRNature's Sunshine Products, Inc. 0.42%11.910.4%$1.14m
CLVRClever Leaves Holdings, Inc. -8.48%1.080.0%$0.90m
CDXCChromadex Corp. -5.24%1.812.7%$0.88m
SMFLSmart for Life, Inc. -8.67%0.480.0%$0.64m
IBIOiBio, Inc. -7.14%0.260.2%$0.59m

Company Profile

XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its pipeline includes hCDR1 and Erythropoietin. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.